| # | Drug | Count |
|---|---|---|
| 0 | BLINATUMOMAB | 11 |
| 1 | ENALAPRIL | 5 |
| 2 | PREDNISOLONE | 5 |
| 3 | PREDNISOLONE ORAL | 5 |
| 4 | PREDNISOLONE ORAL SOLUTION | 5 |
| 5 | AMLODIPINE | 3 |
| 6 | FAMOTIDINE | 3 |
| 7 | FINGOLIMOD HCL | 3 |
| 8 | IBRUTINIB | 3 |
| 9 | MAGNESIUM OXIDE | 3 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BLINATUMOMAB | 11 | 0.0010 |
| 1 | ZONISAMIDE | 2 | 0.0002 |
| 2 | PEGASPARGASE | 2 | 0.0002 |
| 3 | ENALAPRIL | 5 | 0.0001 |
| 4 | ENTECAVIR | 1 | 0.0001 |
| 5 | MAGNESIUM OXIDE | 3 | 0.0001 |
| 6 | TOLVAPTAN | 1 | 0.0001 |
| 7 | METHYLPREDNISOLONE SODIUM SUCCINATE | 3 | 0.0001 |
| 8 | CLARITHROMYCIN | 2 | 0.0001 |
| 9 | HYDROXYUREA | 1 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Asparagine-specific Enzyme [EPC] | 2 | 0.0001 |
| 1 | Vasopressin V2 Receptor Antagonist [EPC] | 1 | 0.0001 |
| 2 | Macrolide Antimicrobial [EPC] | 2 | 0.0000 |
| 3 | Histamine-2 Receptor Antagonist [EPC] | 3 | 0.0000 |
| 4 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 1 | 0.0000 |
| 5 | Topoisomerase Inhibitor [EPC] | 1 | 0.0000 |
| 6 | Osmotic Laxative [EPC] | 3 | 0.0000 |
| 7 | Dihydropyridine Calcium Channel Blocker [EPC] | 3 | 0.0000 |
| 8 | Anti-epileptic Agent [EPC] | 2 | 0.0000 |
| 9 | Nucleoside Metabolic Inhibitor [EPC] | 2 | 0.0000 |